Patents by Inventor Melissa BEILSCHMIDT

Melissa BEILSCHMIDT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLT3 agonist antibodies and uses thereof
    Patent number: 12473365
    Abstract: Described herein are anti-FLT3 agonistic antibodies. Such agonistic antibodies are useful for the expansion of dendritic cells and the treatment of cancer.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: November 18, 2025
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Arif Jetha, Phil Gobeil, Melissa Beilschmidt, Dorothea Maetzel, Johan Fransson
  • DR5-TARGETING MULTABODIES FOR THE TREATMENT OF CANCER
    Publication number: 20240409652
    Abstract: Self-assembled polypeptide complexes comprising 1) fusion polypeptides comprising Fc polypeptides linked to nanocage monomers or subunits thereof and 2) fusion polypeptides comprising an antigen-binding antibody fragment capable of binding to DR5.
    Type: Application
    Filed: September 13, 2022
    Publication date: December 12, 2024
    Inventors: Jean-Philippe Julien, Edurne Rujas Diez, Joanne Hulme, Peter Edward Bayliss, Xinwen He, Melissa Beilschmidt
  • OPTIMIZED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS
    Publication number: 20240400704
    Abstract: Optimized self-assembled poly peptide complexes comprising 1) fusion polypeptides comprising Fc polypeptides linked to nanocage monomers or subunits thereof and 2) fusion polypeptides comprising an antigen-binding antibody fragment.
    Type: Application
    Filed: September 13, 2022
    Publication date: December 5, 2024
    Inventors: Jean-Philippe Julien, Edurne Rujas Diez, Joanne Hulme, Peter Edward Bayliss, Xinwen He, Melissa Beilschmidt
  • FLT3 AGONIST ANTIBODIES AND USES THEREOF
    Publication number: 20220025055
    Abstract: Described herein are anti-FLT3 agonistic antibodies. Such agonistic antibodies are useful for the expansion of dendritic cells and the treatment of cancer.
    Type: Application
    Filed: December 17, 2019
    Publication date: January 27, 2022
    Inventors: Arif JETHA, Phil GOBEIL, Melissa BEILSCHMIDT, Dorothea MAETZEL, Johan FRANSSON